0001209191-19-003104.txt : 20190109 0001209191-19-003104.hdr.sgml : 20190109 20190109171905 ACCESSION NUMBER: 0001209191-19-003104 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190108 FILED AS OF DATE: 20190109 DATE AS OF CHANGE: 20190109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERGER DAVID B CENTRAL INDEX KEY: 0001422126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 19518797 MAIL ADDRESS: STREET 1: 11045 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-08 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001422126 BERGER DAVID B C/O TANDEM DIABETES CARE, INC., 11075 ROSELLE STREET SAN DIEGO CA 92121 0 1 0 0 EVP, GEN. COUNSEL & SECRETARY Common Stock 2019-01-08 4 M 0 10000 2.59 A 11765 D Common Stock 2019-01-08 4 S 0 10000 40.0751 D 1765 D Common Stock 200 I Berger Family Trust Stock Option 2.59 2019-01-08 4 M 0 10000 0.00 D Common Stock 10000 60000 D Represents shares of common stock received upon exercise of a stock option award. The price reported is the weighted average price. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2018, in multiple transactions at prices ranging from $40.00 and $40.15. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Shares are beneficially owned by the Berger Family Trust dated April 16, 2008, for which the Reporting Person is a trustee. Fifty percent (50%) of the underlying shares subject to the option vested on 12/1/2018, and the remaining shares shall vest in twelve (12) equal monthly installments thereafter The expiration date for these options is 10 years from the date of grant. /s/ David B. Berger 2019-01-09